The invention relates to methods for treating chronic liver disease, in particular nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH), with neutrophil elastase inhibitors. The invention further relates to pharmaceutical compositions comprising neutrophil elastase inhibitors.
本发明涉及使用中性粒细胞弹性蛋白酶抑制剂治疗慢性肝病,特别是非
酒精性脂肪性肝病(NAFLD)和非
酒精性脂肪性肝炎(NASH)的方法。本发明还涉及包含中性粒细胞弹性蛋白酶抑制剂的制药组合物。